Format

Send to

Choose Destination
Neurobiol Aging. 2011 Mar;32(3):553.e23-6. doi: 10.1016/j.neurobiolaging.2010.05.016. Epub 2010 Jul 3.

A de novo missense mutation of the FUS gene in a "true" sporadic ALS case.

Author information

1
ALS Center, Department of Neuroscience, University of Torino, Torino, Italy. achio@usa.net

Abstract

Mutations in the Cu/Zn superoxide dismutase (SOD1), transactive response (TAR)-DNA binding protein (TARDBP) and fused in sarcoma (FUS) genes account for approximately 1 third of familial amyotrophic lateral sclerosis (ALS) cases. Mutations in these genes have been found in 1% to 2% of apparently sporadic cases. We present the first case of an ALS patient carrying a de novo missense mutation of the FUS gene (c.1561C>T, p.R521C). This report highlights the importance of screening ALS patients, both familial and sporadic, for FUS mutations and also suggests that de novo mutations is a relevant mechanism underlying sporadic neurodegenerative disease.

[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center